APA

Ma J., Liu C., Yang D., Song J., Zhang J., Wang T., Wang M., Xu W., Li X., Ding S., Zhan J. & Zhang H. (20200515). C1orf106, an innate immunity activator, is amplified in breast cancer and is required for basal-like/luminal progenitor fate decision. : Science China. Life sciences.

Chicago

Ma Ji, Liu Cheng, Yang Decao, Song Jiagui, Zhang Jing, Wang Tianzhuo, Wang Mengyuan, Xu Weizhi, Li Xueying, Ding Shigang, Zhan Jun and Zhang Hongquan. 20200515. C1orf106, an innate immunity activator, is amplified in breast cancer and is required for basal-like/luminal progenitor fate decision. : Science China. Life sciences.

Harvard

Ma J., Liu C., Yang D., Song J., Zhang J., Wang T., Wang M., Xu W., Li X., Ding S., Zhan J. and Zhang H. (20200515). C1orf106, an innate immunity activator, is amplified in breast cancer and is required for basal-like/luminal progenitor fate decision. : Science China. Life sciences.

MLA

Ma Ji, Liu Cheng, Yang Decao, Song Jiagui, Zhang Jing, Wang Tianzhuo, Wang Mengyuan, Xu Weizhi, Li Xueying, Ding Shigang, Zhan Jun and Zhang Hongquan. C1orf106, an innate immunity activator, is amplified in breast cancer and is required for basal-like/luminal progenitor fate decision. : Science China. Life sciences. 20200515.